Postmenopausal hormone therapy and atherosclerosis-time is of the essence

New England Journal of Medicine

Volumn 374, Issue 13, 2016, Pages 1279-1280

  Keaney, John F ^a   Solomon, Caren G ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; PROGESTERONE;

AGE DISTRIBUTION; ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG EFFICACY; EDITORIAL; HORMONAL THERAPY; HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; TIME TO TREATMENT; TREATMENT OUTCOME; CORONARY ARTERY DISEASE; DRUG EFFECTS; ESTROGEN THERAPY; FEMALE;

ATHEROSCLEROSIS; CAROTID INTIMA-MEDIA THICKNESS; CORONARY ARTERY DISEASE; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; POSTMENOPAUSE;

EID: 84962433680     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1602846     Document Type: Editorial

References (12)

1. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epide-miologic evidence. Prev Med 1991; 20: 47-63.
2. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998; 280: 605-13.
3. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-33.
4. Manson JE, Hsia J, Johnson KC, et al. Estrogen plus proges-tin and the risk of coronary heart disease. N Engl J Med 2003; 349:523-34.
5. Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701-12.
6. Hodis HN, Mack WJ, Henderson V W, et al. Vascular effects of early versus late postmenopausal treatment with estradiol. N Engl J Med 2016; 374:1221-31.
7. Bowling MR, Xing D, Kapadia A, et al. Estrogen effects on vascular inflammation are age dependent: role of estrogen receptors. Arterioscler Thromb Vasc Biol 2014; 34: 1477-85.
8. Pinna C, Cignarella A, Sanvito P, Pelosi V, Bolego C. Prolonged ovarian hormone deprivation impairs the protective vascular actions of estrogen receptor alpha agonists. Hypertension 2008;51:1210-7.
9. Salonen JT, Nyyssönen K, Salonen R, et al. Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J Intern Med 2000; 248: 377-86.
10. Manson JE, Chlebowski RT, Stefanick ML, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA 2013; 310: 1353-68.
11. Goodman NF, Cobin RH, Ginzburg SB, Katz IA, Woode DE. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of menopause: executive summary of recommendations. Endocr Pract 2011;17:949-54.
12. ACOG Committee Opinion No. 565: hormone therapy and heart disease. Obstet Gynecol 2013; 121: 1407-10.